Health and Fitness Health and Fitness
Thu, August 30, 2012
[ Thu, Aug 30th 2012 ] - Market Wire
Harvest Properties Acquires Concord Medical Facil .. d for New Tenant Fresenius Medical Care North Ame
[ Thu, Aug 30th 2012 ] - Market Wire
Twelve Iowa Communities Submit Applications to Be .. Blue Zones Project™ Demonstration Sites
[ Thu, Aug 30th 2012 ] - Market Wire
Hospira to Present at the UBS Global Life Sciences Conference Sept. 20, 2012
[ Thu, Aug 30th 2012 ] - Market Wire
Fitch Affirms Attorneys' Liability Assurance Society's IFS at 'A+'; Outlook Stable
[ Thu, Aug 30th 2012 ] - Market Wire
Fitch Affirms Ecopetrol's FC, LC & National LT IDRs at 'BBB-'/'BBB'/'AAA(col)'; Outlook Stable
[ Thu, Aug 30th 2012 ] - Market Wire
Fitch Affirms Hancock Holding's Long-Term IDR at 'BBB+'; Outlook Stable
[ Thu, Aug 30th 2012 ] - Market Wire
Chemed Corporation to Present at the Stifel Nicolaus 2012 Healthcare Conference
[ Thu, Aug 30th 2012 ] - Market Wire
Ironwood and Forest Announce FDA Approval of LINZ .. reatment of Irritable Bowel Syndrome with Constip
[ Thu, Aug 30th 2012 ] - Market Wire
Fitch Publishes Presale Report on TFOVIS 12-3U
[ Thu, Aug 30th 2012 ] - Market Wire
Fitch Affirms SLM Student Loan Trust 2003-8
[ Thu, Aug 30th 2012 ] - Market Wire
St. Jude Medical Realigns Business Units to Suppo .. ies and Announces Changes to Executive Leadership
[ Thu, Aug 30th 2012 ] - Market Wire
Sunshine Heart Submits Investigational Device Exemption to FDA for C-Pulse(R) System Pivotal Trial
[ Thu, Aug 30th 2012 ] - Market Wire
Isis Pharmaceuticals Demonstrates The Potential O .. Antisense Technology To Activate The RNAi Pathway
[ Thu, Aug 30th 2012 ] - Market Wire
Implant Sciences Joins The International Air Cargo Association
[ Thu, Aug 30th 2012 ] - Market Wire
HCA to Present at Health Care Conferences in September
[ Thu, Aug 30th 2012 ] - Market Wire
Clinically Significant 12-Month Results from Card .. 60°; Study Published in Journal of Endovas
[ Thu, Aug 30th 2012 ] - Market Wire
AmSurg Corp. to Present at the Baird 2012 Health Care Conference
[ Thu, Aug 30th 2012 ] - Market Wire
Quest Diagnostics Launches Molecular Cervical Can .. National Institutes of Health's TERC Gene Marker
[ Thu, Aug 30th 2012 ] - Market Wire
Lilly Announces Retirement of Robert Armitage, Na .. rington Senior Vice President and General Counsel
[ Thu, Aug 30th 2012 ] - Market Wire
Bayer Submits New Drug Application for Regorafeni .. eatment of Gastrointestinal Stromal Tumors (GIST)
[ Thu, Aug 30th 2012 ] - Market Wire
Exact Sciences to Participate in September Investor Conferences
[ Thu, Aug 30th 2012 ] - Market Wire
BioSante Pharmaceuticals, Inc. to Present at Stif .. ence and Rodman & Renshaw Global Investment Confe
[ Thu, Aug 30th 2012 ] - Market Wire
Medisafe 1 Technologies in Advanced Negotiations for $7MM Perpetual License Sale
[ Thu, Aug 30th 2012 ] - Market Wire
International Stem Cell Corp to Participate in Upcoming Investor Conferences
[ Thu, Aug 30th 2012 ] - Market Wire
Cerus to Present at the Baird Healthcare Conference on September 6, 2012
[ Thu, Aug 30th 2012 ] - Market Wire
ArQule, Inc. to Present at Upcoming Investment Conferences
[ Thu, Aug 30th 2012 ] - Market Wire
Bio-Reference Laboratories, Inc. Reports Best Qua .. in Corporate History with 25% Increase in Earning
[ Thu, Aug 30th 2012 ] - Market Wire
Affordable Hearing Aids Now Available to Millions of UnitedHealthcare Health Plan Customers
[ Thu, Aug 30th 2012 ] - Market Wire
Merger and Acquisition Activity Within the Biotech Industry Soars to a Four-Year High
[ Thu, Aug 30th 2012 ] - Market Wire
Trimel to Present at the Upcoming Investor Conferences

Trimel to Present at the Upcoming Investor Conferences


Published on 2012-08-30 05:32:49 - Market Wire
  Print publication without navigation


August 30, 2012 08:00 ET

Trimel to Present at the Upcoming Investor Conferences

TORONTO, ONTARIO--(Marketwire - Aug. 30, 2012) - Trimel Pharmaceuticals Corporation (TSX:TRL) (the "Company" or "Trimel") today announced that it will participate in the Stifel Nicolaus 2012 Healthcare Conference at the Four Seasons Hotel in Boston, MA on September 6th, 2012 at 4:25pm EDT and the Rodman and Renshaw 14th Annual Global Investment Conference at the Waldorf Astoria Hotel in New York, NY on September 10th, 2012 at 2:25pm EDT.

Mr. Kenneth Howling, Chief Financial Officer, is scheduled to present an overview of the Company at the upcoming conferences. The presentation materials will also be available on the Trimel website at [ www.trimelpharmaceuticals.com ].

For further information regarding Trimel Pharmaceuticals Corporation, please contact Kenneth Howling, Chief Financial Officer at (416) 679-0536 or Trimel via email at [ ir@trimelpharmaceuticals.com ].

About Trimel

Trimel Pharmaceuticals Corporation (TSX:TRL) - Developing medications for Female Sexual Health and conditions related to Aging, and Well Being. Trimel is developing multiple product opportunities, including CompleoTRT™, a bio-adhesive intranasal Testosterone gel currently in Phase III clinical testing in the United States. CompleoTRT™ is under investigation for the treatment of male hypogonadism, a condition commonly referred to as "Low T". For more information, please visit [ www.trimelpharmaceuticals.com ].



Contributing Sources